FORA (Forian) 10-Year Sharpe Ratio: N/A (As of Sep. 08, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FORA Forian Inc FORA
46 GF Score
Price $2.17
GF Value $3.27
! 4 Warning Signs
View Full Analysis

What is Forian 10-Year Sharpe Ratio?

The 10-Year Sharpe Ratio measures the additional return that an investor receives per unit of increase in risk over the past ten years. As of today (2026-09-08), Forian's 10-Year Sharpe Ratio is Not available.


Forian  (NAS:FORA) 10-Year Sharpe Ratio Explanation

The 10-Year Sharpe Ratio inidicates the risk-adjusted return of an investment over the past ten years. It is calculated as the annualized result of the average ten-year monthly excess returns divided by its standard deviation in the ten-year period. The monthly excess return is the monthly investment return minus the monthly risk-free rate (typically the 10-year Treasury Constant Maturity Rate). If the risk-free rate for a specific region is not available, U.S. data is used by default.

The greater a portfolio's Sharpe Ratio, the better its risk-adjusted performance. A negative Sharpe Ratio means the risk-free rate is greater than the portfolio’s historical or projected return, or else the portfolio's return is expected to be negative.


Forian 10-Year Sharpe Ratio Related Terms


FORA vs DRIO, ONMD, BEAT: 10-Year Sharpe Ratio Comparison

For the Health Information Services subindustry, Forian's 10-Year Sharpe Ratio, along with its competitors' market caps and 10-Year Sharpe Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Forian 10-Year Sharpe Ratio vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Forian's 10-Year Sharpe Ratio distribution charts can be found below:

* The bar in red indicates where Forian's 10-Year Sharpe Ratio falls into.


FORA
46GF Score
Forian Inc FORA
10-Year Sharpe Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Forian 10-Year Sharpe Ratio Calculation

The 10-Year Sharpe Ratio measures the performance of an investment such as a stock or portfolio compared to a risk-free asset in the last ten years. A stock / portfolio's 10-Year Sharpe Ratio can be calculated by dividing the difference between the ten-year average monthly returns of the investment and the risk-free rate, by the standard deviation of the investment returns over the past ten years.

Is Forian (FORA) Overvalued in 2026?

Based on GuruFocus' analysis, Forian stock appears to be undervalued. The current stock price of $2.17 is trading 33.6% below its estimated GF Value™ of $3.27.

Key valuation signals for FORA:

  • 10-Year Sharpe Ratio: N/A
  • GF Value™: $3.27 vs. price of $2.17 (33.6% below fair value)
  • GF Score™: 46/100 with 4 warning signs

No single metric tells the full story. See the FORA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Forian Business Description

Address 41 University Drive, Suite 400, Newtown, PA, USA, 18940
Forian Inc provides a suite of Software, data management capabilities, and proprietary data and analytics to optimize and measure operational, clinical, and financial performance for customers within the traditional and emerging life sciences, healthcare payer, and provider segments, as well as cannabis dispensaries, manufacturers, and cultivators.
46GF Score

Get the complete analysis for FORA

10-Year Sharpe Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.17
Price
$3.27
GF Value